BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26755453)

  • 1. Spinal cord glioblastoma: 25years of experience from a single institution.
    Yanamadala V; Koffie RM; Shankar GM; Kumar JI; Buchlak QD; Puthenpura V; Frosch MP; Gudewicz TM; Borges LF; Shin JH
    J Clin Neurosci; 2016 May; 27():138-41. PubMed ID: 26755453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Features and Outcomes of Primary Spinal Cord Glioblastoma: A Single-Center Experience and Literature Review.
    Yang K; Man W; Jing L; Sun Z; Liang P; Wang J; Wang G
    World Neurosurg; 2020 Nov; 143():e157-e165. PubMed ID: 32688042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Spinal Cord Glioblastoma Multiforme: A Retrospective Study of Patients at a Single Institution.
    Cheng X; Lou S; Huang S; Chen H; Liu J
    World Neurosurg; 2017 Oct; 106():113-119. PubMed ID: 28377242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.
    Konar SK; Bir SC; Maiti TK; Nanda A
    J Neurosurg Pediatr; 2017 Feb; 19(2):239-248. PubMed ID: 27813458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Patients with Primary Intramedullary Spinal Cord Glioblastoma.
    Behmanesh B; Setzer M; Konczalla J; Harter P; Quick-Weller J; Imoehl L; Franz K; Gessler F; Seifert V; Marquardt G
    World Neurosurg; 2017 Feb; 98():198-202. PubMed ID: 27777151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal cord stimulation as adjuvant during chemotherapy and reirradiation treatment of recurrent high-grade gliomas.
    Clavo B; Robaina F; Jorge IJ; Cabrera R; Ruiz-Egea E; Szolna A; Otermin E; Llontop P; Carames MA; Santana-Rodríguez N; Sminia P
    Integr Cancer Ther; 2014 Nov; 13(6):513-9. PubMed ID: 25228535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of spinal cord glioblastoma multiforme].
    Yamazaki M; Ikota T; Ohkata N; Tashiro T; Sawamura Y; Iwasaki Y; Abe H
    No Shinkei Geka; 1992 Jan; 20(1):85-9. PubMed ID: 1310803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
    Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
    J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Characterization of a Multifocal Ganglioglioma Originating Within the Spinal Cord.
    Wang JL; Hong CS; Otero J; Puduvalli VK; Elder JB
    World Neurosurg; 2016 Dec; 96():608.e1-608.e4. PubMed ID: 27671879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?
    Zanello M; Roux A; Ursu R; Peeters S; Bauchet L; Noel G; Guyotat J; Le Reste PJ; Faillot T; Litre F; Desse N; Emery E; Petit A; Peltier J; Voirin J; Caire F; Barat JL; Vignes JR; Menei P; Langlois O; Dezamis E; Carpentier A; Dam Hieu P; Metellus P; Pallud J;
    J Neurooncol; 2017 Nov; 135(2):285-297. PubMed ID: 28726173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
    Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
    Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor prognosis despite aggressive treatment in adults with intramedullary spinal cord glioblastoma.
    Liu A; Sankey EW; Bettegowda C; Burger PC; Jallo GI; Groves ML
    J Clin Neurosci; 2015 Oct; 22(10):1628-31. PubMed ID: 26142051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric intramedullary spinal cord tumors: a single center experience.
    Kutluk T; Varan A; Kafalı C; Hayran M; Söylemezoğlu F; Zorlu F; Aydın B; Yalçın B; Akyüz C; Büyükpamukçu M
    Eur J Paediatr Neurol; 2015 Jan; 19(1):41-7. PubMed ID: 25457509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentric Exophytic Primary Spinal Cord Glioblastoma Mimicking Teratoma.
    Yang K; Wang J; Wang G
    World Neurosurg; 2020 Dec; 144():262-263.e2. PubMed ID: 32777408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and functional outcome of childhood spinal cord low-grade gliomas. Clinical article.
    Scheinemann K; Bartels U; Huang A; Hawkins C; Kulkarni AV; Bouffet E; Tabori U
    J Neurosurg Pediatr; 2009 Sep; 4(3):254-61. PubMed ID: 19772410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervicomedullary tumors in children.
    McAbee JH; Modica J; Thompson CJ; Broniscer A; Orr B; Choudhri AF; Boop FA; Klimo P
    J Neurosurg Pediatr; 2015 Oct; 16(4):357-66. PubMed ID: 26114990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathological outcomes after resection of intramedullary spinal cord tumors: a single-institution case series.
    Samuel N; Tetreault L; Santaguida C; Nater A; Moayeri N; Massicotte EM; Fehlings MG
    Neurosurg Focus; 2016 Aug; 41(2):E8. PubMed ID: 27476850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of spinal cord metastasis from brain glioblastomas.
    Amelot A; Terrier LM; Cognacq G; Jecko V; Marlier B; Seizeur R; Emery E; Bauchet L; Roualdes V; Voirin J; Joubert C; Mandonnet E; Lemnos L; Mathon B; Le Reste PJ; Coca A; Petit A; Rigau V; Mokhtari K; Rousseau A; Metellus P; Figarella-Branger D; Gauchotte G; Farah K; Pallud J; Zemmoura I
    J Neurooncol; 2023 Apr; 162(2):373-382. PubMed ID: 36991306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide.
    Lechapt-Zalcman E; Levallet G; Dugué AE; Vital A; Diebold MD; Menei P; Colin P; Peruzzy P; Emery E; Bernaudin M; Chapon F; Guillamo JS
    Cancer; 2012 Sep; 118(18):4545-54. PubMed ID: 22359215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.